0001209191-16-149432.txt : 20161110
0001209191-16-149432.hdr.sgml : 20161110
20161110173803
ACCESSION NUMBER: 0001209191-16-149432
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161108
FILED AS OF DATE: 20161110
DATE AS OF CHANGE: 20161110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AQUINOX PHARMACEUTICALS, INC
CENTRAL INDEX KEY: 0001404644
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 887 GREAT NORTHERN WAY
STREET 2: SUITE 450
CITY: VANCOUVER
STATE: A1
ZIP: V5T 4T5
BUSINESS PHONE: 604-629-9223
MAIL ADDRESS:
STREET 1: 887 GREAT NORTHERN WAY
STREET 2: SUITE 450
CITY: VANCOUVER
STATE: A1
ZIP: V5T 4T5
FORMER COMPANY:
FORMER CONFORMED NAME: AQUINOX PHARMACEUTICALS (USA) INC
DATE OF NAME CHANGE: 20070626
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Troupin Barbara
CENTRAL INDEX KEY: 0001627886
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36327
FILM NUMBER: 161989346
MAIL ADDRESS:
STREET 1: C/O APRICUS BIOSCIENCES, INC.
STREET 2: 11975 EL CAMINO REAL, SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-11-08
0
0001404644
AQUINOX PHARMACEUTICALS, INC
AQXP
0001627886
Troupin Barbara
C/O AQUINOX PHARMACEUTICALS, INC.
450 - 887 GREAT NORTHERN WAY
VANCOUVER
A1
V5T 4T5
BRITISH COLUMBIA, CANADA
0
1
0
0
Chief Medical Officer
Stock Option (Right to Buy)
11.77
2016-11-08
4
A
0
50000
0.00
A
2026-11-07
Common Stock
50000
50000
D
The shares subject to this option shall vest and become exercisable at a rate of twenty-five percent of the total number of shares underlying the options on the one-year anniversary of October 3, 2016 (the "Vesting Commencement Date") and 1/48th of the total number of shares underlying the options each monthly anniversary of the Vesting Commencement Date thereafter for so long as the recipient of the option provides continuous service to the issuer, such that the total number of shares underlying the options shall be fully vested on the four-year anniversary of the Vesting Commencement Date.
/s/ Barbara Troupin
2016-11-10